Interestingly, TPI1 functions as a serum biomarker in several malignancies, including breast cancer, lung squamous cell carcinoma, and hepatocellular carcinoma (HCC), although conflicting evidence has also suggested a tumor-suppressive role in HCC [22,26,27]. This evidence concerns the gene TPI1 and hepatocellular carcinoma.